BIO-FD&C Co.,Ltd. (KOSDAQ:251120)

Market Cap	133.91B +12.4%
Revenue (ttm)	18.82B +17.1%
Net Income	7.08B +38.9%
EPS	830.83 +38.9%
Shares Out	8.70M
PE Ratio	18.54
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,339
Average Volume	34,746
Open	15,520
Previous Close	n/a
Day's Range	15,410 - 15,880
52-Week Range	12,230 - 23,100
Beta	0.58
RSI	50.58
Earnings Date	n/a

About BIO-FD&C

BIO-FD&C Co.,Ltd. develops active ingredients for anti-aging cosmetics in South Korea. It offers plant cell, peptide, natural extract, and biomolecule products for wrinkle improvement/skin regeneration, skin brightening, acne, skin irritation, wound healing, scalp improvement, skin moisturizing, fine dust, hair loss improvement, pores, lifting, whitening, skin texture, anti-inflammation/skin soothing, and anti-oxidation. The company was founded in 2005 and is headquartered in Incheon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2005
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 251120

Financial Performance

In 2024, BIO-FD&C's revenue was 16.07 billion, an increase of 3.04% compared to the previous year's 15.59 billion. Earnings were 4.50 billion, a decrease of -19.41%.